PharmaCyte Biotech's total assets for Q3 2026 were $55.87M, a decrease of -0.18% from the previous quarter. PMCB total liabilities were $16.47M for the fiscal quarter, a -15.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.